000 03038nam a22005295i 4500
001 978-94-007-5028-9
003 DE-He213
005 20140220083347.0
007 cr nn 008mamaa
008 121116s2012 ne | s |||| 0|eng d
020 _a9789400750289
_9978-94-007-5028-9
024 7 _a10.1007/978-94-007-5028-9
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a614.5999
_223
100 1 _aTao, Jianguo.
_eeditor.
245 1 0 _aHematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics
_h[electronic resource] /
_cedited by Jianguo Tao, Eduardo Sotomayor.
264 1 _aDordrecht :
_bSpringer Netherlands :
_bImprint: Springer,
_c2012.
300 _aVI, 426 p. 26 illus., 20 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aCancer Growth and Progression ;
_v14
520 _aIn the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies. 
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aMedical laboratories.
650 0 _aHematology.
650 0 _aCytology.
650 1 4 _aBiomedicine.
650 2 4 _aCancer Research.
650 2 4 _aHematology.
650 2 4 _aLaboratory Medicine.
650 2 4 _aMolecular Medicine.
650 2 4 _aApoptosis.
650 2 4 _aCell Biology.
700 1 _aSotomayor, Eduardo.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789400750272
830 0 _aCancer Growth and Progression ;
_v14
856 4 0 _uhttp://dx.doi.org/10.1007/978-94-007-5028-9
912 _aZDB-2-SME
999 _c104837
_d104837